KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Current Deferred Revenue (2016 - 2025)

Humana (HUM) has disclosed Current Deferred Revenue for 16 consecutive years, with $356.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue changed N/A to $356.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $356.0 million, a N/A change, with the full-year FY2025 number at $356.0 million, changed N/A from a year prior.
  • Current Deferred Revenue was $356.0 million for Q4 2025 at Humana, up from $265.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $7.5 billion in Q3 2023 to a low of $254.0 million in Q4 2021.
  • A 4-year average of $2.1 billion and a median of $288.0 million in 2022 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: dropped 20.13% in 2021, then surged 2694.7% in 2023.
  • Humana's Current Deferred Revenue stood at $254.0 million in 2021, then grew by 12.6% to $286.0 million in 2022, then surged by 2534.97% to $7.5 billion in 2023, then plummeted by 95.28% to $356.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Current Deferred Revenue are $356.0 million (Q4 2025), $265.0 million (Q3 2025), and $274.0 million (Q2 2025).